Is VKTX Heading to $100?

Shares of biopharmaceutical stock VKTX soared about 25% . The company announced early positive study results for its oral weight-loss drug. VKTX said the drug's Phase 1 clinical trial focused on evaluating its safety and significantly exceed market expectations. ---------------- Are weight loss drugs good investing choices? Will you add weight loss drugs as they continue to hit new records?

avatarAlva Robinson
03-28
$Viking Therapeutics(VKTX)$ 100 no problem of course this time verified dose effect back this drug market volume expectations come easy up
RepostReply
avatarRyan_Z0528
03-28

$VKTX Buyout incoming any day now. Expecting buyout at $160+. Potentially $200+

Shares of $Viking Therapeutics(VKTX)$ were up 16.8% on Mar 26 after it announced positive data from an early-stage study that an oral formulation of VK2735, its investigational obesity drug.Year to date, shares of Viking Therapeutics have skyrocketed 334.3% against the industry’s 0.9% fall.Zacks Investment ResearchI pointed in <Is VTRX the Next Big Competitor to LLY & NVO? Surge of 121% Signals Potential Growth Ahead> on 28th FebAt that time, the company soared 121%. At that time, the results of the phase 2 VENTURE study of the company's weight loss drug candidate VK2735 were positive. It said in an openly irresponsible voice that its future destination would be to be
201
$VKTX Buyout incoming any day now. Expecting buyout at $160+. Potentially $200+
avatarJoanne Elinor
03-28
Being someone who is adjacent to the health + wellness field I'm watching the insatiable (pun intended) hunger for weight loss drugs. As they are developing GLP-1 style drugs, even though there's no long term research yet, so who knows, there's a big band wagon to hop on to.And I have individual stock holdings in $Viking Therapeutics, Inc.(VKTX)$ Wait for Heading to $100! Is there anyone who hasn't joined?
RepostReply
avatarWadeKellogg
03-28
It is a bit ironic that $Viking Therapeutics, Inc.(VKTX)$ and $Krispy Kreme, Inc.(DNUT)$ have a big jump on the same day. We want to lose weight, but we also want to keep eating donuts.[LOL]"Best in class oral weight loss drug. it got really good efficacy and tolerability. It could potentially going for higher dosage" Stock $Viking Therapeutics, Inc.(VKTX)$ may got upgraded to 138! The demand for weight loss drug cannot be underestimated.
RepostReply
avatarJeromeErnest
03-27

80 seems overvalued for VKTX

80 is enuf!!! $Viking Therapeutics, Inc.(VKTX)$ While VKTX-2735 has shown promising safety profiles in early studies, ramping up the dosage could potentially introduce unforeseen risks. Investors might fret over increased adverse reactions with higher doses, casting doubt on its commercial viability and market acceptancetho its potential for significant weight loss, VKTX-2735 faces an uphill battle in a fiercely competitive weight loss drug market. established players like Semaglutide and Tirzepatide already dominate, raising questions about VKTX-2735's ability to carve out a significant market share and achieve commercial successand VKTX-2735 is still in the clinical trial phase, and its path to market approval depends o
20Reply
80 seems overvalued for VKTX
avatarTrevelyan
03-27

If VKTX-2735 can grab just a slice of that market share the stock price gonna be 200

100? 200!!!!!!!!The weight loss pill war is heating up with a new player entering the arena! VKTX-2735 is rocking it with its amazing safety profile and clear dose response. This means there's room to up the dosage for even better weight loss results! Can't wait for that! $Novo-Nordisk A/S(NVO)$ Sales of Semaglutide have already hit a whopping $21.01 billion! $Eli Lilly(LLY)$ Tirzepatide sales reached $5.163 billion in 2023. If VKTX-2735 can grab just a slice of that market share with its dose response, easily taking $15 billion, its current market cap of less than $10 billion is a total steal! It's like $Viking Therapeutics(VKTX)$ hitting
132
If VKTX-2735 can grab just a slice of that market share the stock price gonna be 200
avatarAlex Puffin On Two Smokes
03-26
RepostReply
avatarkoolgal
03-01
🌟🌟🌟Next to AI and Bitcoin, Obesity Drugs are big this year. $Viking Therapeutics(VKTX)$ said on Tuesday this week that its experimental drug helped patients with obesity lose nearly 15% of their body weight.  As a result Viking Therapeutics Share price has skyrocketed more than 100% in the past 5 days.  Viking Therapeutics is hoping for a share of the potential USD 100 billion obesity treatment market currently dominated by $Eli Lilly(LLY)$ and $Novo-Nordisk A/S(NVO)$ .
@虎港通:【🎁有獎話題】減肥神葯概念股暴漲！除咗AI幣股，減肥葯也將主導24年股市？
Repost4
avatarHav
03-01
RepostReply